Article Details

Akero drug for NASH misses goal in mid-stage study - BioPharma Dive

Retrieved on: 2023-10-10 16:29:40

Tags for this article:

Click the tags to see associated articles and topics

Akero drug for NASH misses goal in mid-stage study - BioPharma Dive. View article details on hiswai:

Excerpt

Shares in Akero Therapeutics fell in value by nearly two-thirds Tuesday after the biotechnology ... Akero is one of many biotechnology companies that ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up